Sona Nanotech Inc (TSE:SONA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sona Nanotech Inc. announced promising results from its preclinical study using Targeted Hyperthermia Therapy to treat colorectal cancer, which showed enhanced response rates when combined with standard immunotherapy. The study revealed that tumors in mice were significantly reduced, with half of them eliminated, demonstrating the potential of the therapy to convert resistant cancers into responsive ones.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
